Effect of the Dietary Supplement SAMe on Blood Homocysteine Levels

Completed · Not applicable · Has a placebo group

Conditions studied: Heart Disease

In brief

The purpose of this study is to determine if the oral intake of the dietary supplement SAMe increases blood homocysteine levels in healthy human subjects.

Key facts

Study ID

NCT00284011

Run by

Mayo Clinic

People needed

52

Starts

2005-06-01

Expected to finish

2006-05-01

Last updated by the study team

2012-01-06

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Women and men age 18 - 65
• Able to understand and sign a consent form

You may not qualify if…

• Smoking
• Pregnant or lactating
• Women actively trying to conceive
• Diagnosis of panic disorder or bipolar disorder

Where it is running

• Mayo Clinic — Rochester, Minnesota, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.